NDC 76357-599-02 - SmartMouth SmartMouth Gum Health Zinc Activated Formula
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76357-599
- Requested NDC
- 76357-599-02
- Package NDCs from labels
- 76357-599-02
- Manufacturer
- Triumph Pharmaceuticals, Inc.
- Effective date
- 2024-12-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SmartMouth Gum Health Solution 1 - Triumph Pharmaceuticals, Inc. | Triumph Pharmaceuticals, Inc. | 2024-12-12 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76357-599-02 | SmartMouth SmartMouth Gum Health Zinc Activated Formula | 237 mL in 1 BOTTLE | LIQUID | 237 mL | 500 mg in 20mL | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Health | CETYLPYRIDINIUM CHLORIDE | Walgreen Co. | 698f7c5a-11d4-4ea9-811d-9c2ffb4df71e | 2026-02-12 | Warnings, Adverse reactions | D9OM4SK49P |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Cetylpyridinium Chloride | CETYLPYRIDINIUM CHLORIDE | Walgreen Co. | 476df2f5-42fa-edc2-e063-6294a90a7b5c | 2026-02-11 | Warnings, Adverse reactions | 1251617 D9OM4SK49P |
| CVS Antiseptic | CETYLPYRIDINIUM CHLORIDE | CVS Pharmacy, Inc. | 60f6a6b5-a3d6-49fc-9543-113ef0205dd2 | 2026-02-11 | Warnings, Adverse reactions | D9OM4SK49P |
| Walgreens ULTRA FINE MOISTURIZING SALINE MIST | NASAL MIST | WALGREEN COMPANY | 48fef521-1b1d-d0d5-e063-6394a90ac7b1 | 2026-02-10 | Warnings | 451W47IQ8X |
| Walgreens SALINE MIST | NASAL MIST | WALGREEN COMPANY | 44815675-cc1d-a582-e063-6394a90ae8f6 | 2026-02-10 | Warnings | 451W47IQ8X |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Droptics Performance Eye Drops | NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL | Droptics LLC | 20fd6822-a7fd-4593-92bb-0a07260893e2 | 2026-02-09 | Warnings | 6DC9Q167V3 |
| Multi-Action Antiseptic | CETYLPYRIDINIUM CHLORIDE | American Sales Company | a0656c06-1df9-48d9-91e2-af0833f7bd75 | 2026-02-06 | Warnings, Adverse reactions | D9OM4SK49P |
| 0.9 percentsaline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 487cb4fc-2e0b-020f-e063-6294a90a4526 | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e76aca-ca2b-3b95-e063-6394a90a875e | 2026-02-03 | Warnings | 451W47IQ8X |
| 0.9%saline | SODIUM CHLORIDE | Huizhou Jinsheng Medical Technology Co., Ltd | 49e7b329-e4e5-6991-e063-6294a90ac817 | 2026-02-03 | Warnings | 451W47IQ8X |
| Antispetic | CETYLPYRIDINIUM CHLORIDE | Demoulas Super Markets, Inc | 0162bc02-9c93-4f15-883c-68794c92e64d | 2026-02-03 | Warnings, Adverse reactions | D9OM4SK49P |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Alcohol Free Antiseptic | CETYLPYRIDINIUM CHLORIDE | Rite Aid Corporation | 69b8649b-1876-4c3a-a64d-5476edbe0a4a | 2026-01-30 | Warnings, Adverse reactions | D9OM4SK49P |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.